OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS

A. Spira; Matthew Krebs; B.C. Cho; B. Besse; J. Goldman; P. Janne; C.K. Lee; Z. Ma; A. Mansfield; A. Minchom; S. Ou; R. Salgia; Z. Wang; G. Gao; J. Curtin; A. Roshak; R. Schnepp; M. Thayu; R. Knoblauch; José Trigo

doi:10.1016/j.jtho.2021.08.084

OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS

A. Spira, Matthew Krebs, B.C. Cho, B. Besse, J. Goldman, P. Janne, C.K. Lee, Z. Ma, A. Mansfield, A. Minchom, S. Ou, R. Salgia, Z. Wang, G. Gao, J. Curtin, A. Roshak, R. Schnepp, M. Thayu, R. Knoblauch, José Trigo

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S874-S875
Journal	Journal of Thoracic Oncology
Volume	16
DOIs	https://doi.org/10.1016/j.jtho.2021.08.084
Publication status	Published - 1 Oct 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jtho.2021.08.084

Cite this

Spira, A., Krebs, M., Cho, B. C., Besse, B., Goldman, J., Janne, P., Lee, C. K., Ma, Z., Mansfield, A., Minchom, A., Ou, S., Salgia, R., Wang, Z., Gao, G., Curtin, J., Roshak, A., Schnepp, R., Thayu, M., Knoblauch, R., & Trigo, J. (2021). OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS. Journal of Thoracic Oncology, 16, S874-S875. https://doi.org/10.1016/j.jtho.2021.08.084

@article{9c6ba93473a241758000a3e9ff0261db,

title = "OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS",

author = "A. Spira and Matthew Krebs and B.C. Cho and B. Besse and J. Goldman and P. Janne and C.K. Lee and Z. Ma and A. Mansfield and A. Minchom and S. Ou and R. Salgia and Z. Wang and G. Gao and J. Curtin and A. Roshak and R. Schnepp and M. Thayu and R. Knoblauch and Jos{\'e} Trigo",

year = "2021",

month = oct,

day = "1",

doi = "10.1016/j.jtho.2021.08.084",

language = "English",

volume = "16",

pages = "S874--S875",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier BV",

}

Spira, A, Krebs, M, Cho, BC, Besse, B, Goldman, J, Janne, P, Lee, CK, Ma, Z, Mansfield, A, Minchom, A, Ou, S, Salgia, R, Wang, Z, Gao, G, Curtin, J, Roshak, A, Schnepp, R, Thayu, M, Knoblauch, R & Trigo, J 2021, 'OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS', Journal of Thoracic Oncology, vol. 16, pp. S874-S875. https://doi.org/10.1016/j.jtho.2021.08.084

TY - JOUR

T1 - OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS

AU - Spira, A.

AU - Krebs, Matthew

AU - Cho, B.C.

AU - Besse, B.

AU - Goldman, J.

AU - Janne, P.

AU - Lee, C.K.

AU - Ma, Z.

AU - Mansfield, A.

AU - Minchom, A.

AU - Ou, S.

AU - Salgia, R.

AU - Wang, Z.

AU - Gao, G.

AU - Curtin, J.

AU - Roshak, A.

AU - Schnepp, R.

AU - Thayu, M.

AU - Knoblauch, R.

AU - Trigo, José

PY - 2021/10/1

Y1 - 2021/10/1

U2 - 10.1016/j.jtho.2021.08.084

DO - 10.1016/j.jtho.2021.08.084

M3 - Meeting Abstract

SN - 1556-0864

VL - 16

SP - S874-S875

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

ER -